NEW YORK, Nov 1 – Blackstone Technology Group announced Wednesday that it will build a large-scale, distributed compute farm system for Biogen.
Financial terms of the deal were not disclosed.
Blackstone will provide a high-performance compute farm based on the Linux operating system and Intel-based processors to support Biogen's drug discovery efforts. The Linux farm will interoperate with Biogen's existing Unix infrastructure, which consists of Sun hardware running Solaris and SGI hardware running Irix.
Biogen will receive Blackstone's SmartBlast tool for distributing computationally-intensive genomic applications across compute farms and its SmartCache data management tool to speed data flow across the farm.
The biotech company will also get Blackstone's SmartWatch software to monitor CPU usage rates and efficiency levels as well as LSF load-balancing software from Platform Computing, which optimizes processing across CPUs in the compute farm.
Ron Ranauro, founder and chief executive officer of Blackstone, said, “We're very excited that Biogen selected us to work with them to build a fast and efficient computing platform to speed their drug discovery.”